Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Puma Biotech Gets FDA Nod of Labeling Supplement for Nerlynx
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Expands Pierre Fabre License to Add Countries
Why Puma Biotechnology, Inc. Stock Soared 65.1% in July | Fox Business